New method to screen Alzheimer's inhibitors offers hope for treatment breakthrough.
The researchers developed a method to prepare and analyze toxic Aβ1-42 oligomers, which are linked to Alzheimer's disease. They used a specific antibody to detect these harmful oligomers in samples, allowing for the screening of potential inhibitors. This approach can help identify compounds that may prevent neurodegeneration in Alzheimer's disease.